Overview
Stefan Piechnik practices practicing medicine in Oxford, United Kingdom.
Mr. Piechnik is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Myocarditis, Hypertrophic Cardiomyopathy (HCM), Heart Attack, and Percutaneous Coronary Intervention (PCI).
He is actively involved in clinical research, co-authoring 156 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Stefan K. Piechnik
Is Stefan K. Piechnik a top-rated expert for Cardiomyopathy?
MediFind is an objective health platform that identifies experts based on real-world data. Stefan K. Piechnik is classified as an Distinguished expert for Cardiomyopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Stefan K. Piechnik participate in research or clinical trials?
Yes. Stefan K. Piechnik has published 155 articles and abstracts on conditions like Cardiomyopathy. You can view a list of Stefan K. Piechnik's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- CardiomyopathyMr. Piechnik isDistinguished. Learn about Cardiomyopathy.
- Hypertrophic Cardiomyopathy (HCM)Mr. Piechnik isDistinguished. Learn about Hypertrophic Cardiomyopathy (HCM).
- MyocarditisMr. Piechnik isDistinguished. Learn about Myocarditis.
- Advanced
- Heart AttackMr. Piechnik isAdvanced. Learn about Heart Attack.
- Heart FailureMr. Piechnik isAdvanced. Learn about Heart Failure.
- Experienced
- AnemiaMr. Piechnik isExperienced. Learn about Anemia.
- AnginaMr. Piechnik isExperienced. Learn about Angina.
- Aortic Valve StenosisMr. Piechnik isExperienced. Learn about Aortic Valve Stenosis.
- Atrial FibrillationMr. Piechnik isExperienced. Learn about Atrial Fibrillation.
- Cardiac AmyloidosisMr. Piechnik isExperienced. Learn about Cardiac Amyloidosis.
- Coronary Heart DiseaseMr. Piechnik isExperienced. Learn about Coronary Heart Disease.
- COVID-19Mr. Piechnik isExperienced. Learn about COVID-19.
- Dilated Cardiomyopathy (DCM)Mr. Piechnik isExperienced. Learn about Dilated Cardiomyopathy (DCM).
- Familial Dilated CardiomyopathyMr. Piechnik isExperienced. Learn about Familial Dilated Cardiomyopathy.
- Heart Failure with Preserved Ejection Fraction (HFpEF)
- HypertensionMr. Piechnik isExperienced. Learn about Hypertension.
- IgG4-Related DiseaseMr. Piechnik isExperienced. Learn about IgG4-Related Disease.
- Iron Deficiency AnemiaMr. Piechnik isExperienced. Learn about Iron Deficiency Anemia.
- Long Haul COVIDMr. Piechnik isExperienced. Learn about Long Haul COVID.
- Mitral Valve ProlapseMr. Piechnik isExperienced. Learn about Mitral Valve Prolapse.
- Percutaneous Coronary Intervention (PCI)Mr. Piechnik isExperienced. Learn about Percutaneous Coronary Intervention (PCI).
- PheochromocytomaMr. Piechnik isExperienced. Learn about Pheochromocytoma.
- Primary AmyloidosisMr. Piechnik isExperienced. Learn about Primary Amyloidosis.
- Severe Acute Respiratory Syndrome (SARS)Mr. Piechnik isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).
- Systemic Lupus Erythematosus (SLE)Mr. Piechnik isExperienced. Learn about Systemic Lupus Erythematosus (SLE).
- Type 2 Diabetes (T2D)Mr. Piechnik isExperienced. Learn about Type 2 Diabetes (T2D).